Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Discover how Temple Lung Center’s innovative clinical trials provide early access to breakthrough treatments and enhanced ...

A new study finds that KL-6 and hSP-D levels can help predict progression of interstitial lung disease in patients with ...

Pulmonary hypertension is a common consequence of interstitial lung disease (PH-ILD), with the highest rate seen among ...

Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis, setting up regulatory filings. The new data from the 1,178-patient FIBRONEER-ILD study ...

Jobs with high IPF mortality ratios differed by sex ... placebo, according to FIBRONEER-ILD topline results. Treatment with TNF inhibitors yielded no differences in outcomes vs.

the Vanderbilt Idiopathic Pulmonary Fibrosis and ILD Research Program has participated in and/or completed over 80 clinical trials and registries. This included Dr. Lancaster serving as a ...